Showing results (131-140 of 153) with videos related to

Sort By:
Pageof 16
The American Journal of Pathology|January 3, 2012
PTEN regulates PDGF ligand switch for β-PDGFR signaling in prostate cancerM Katie Conley-LaComb, Wei Huang, Shihua Wang, et al.
The Prostate|January 4, 2012
Cediranib inhibits both the intraosseous growth of PDGF D-positive prostate cancer cells and the associated bone reactionAbdo J Najy, Young Suk Jung, Joshua J Won, et al.
Molecular Cancer Research : MCR|August 7, 2013
Transcriptional regulation of CXCR4 in prostate cancer: significance of TMPRSS2-ERG fusionsRajareddy Singareddy, Louie Semaan, M Katie Conley-Lacomb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2015
ERG/AKR1C3/AR Constitutes a Feed-Forward Loop for AR Signaling in Prostate Cancer CellsKatelyn Powell, Louie Semaan, M Katie Conley-LaComb, et al.
BJU International|May 7, 2026
Urologist and radiologist contributions to variation in prostate cancer detection at fusion biopsyDaniel Triner, Kevin B Ginsburg, Ana Moser, et al.
Neoplasia (New York, N.Y.)|August 21, 2008
C-kit and its ligand stem cell factor: potential contribution to prostate cancer bone metastasisChristoph Wiesner, Sanaa M Nabha, Emanuel Burck Dos Santos, et al.
The American Journal of Pathology|May 26, 2007
Prostate cancer-associated membrane type 1-matrix metalloproteinase: a pivotal role in bone response and intraosseous tumor growthR Daniel Bonfil, Zhong Dong, J Carlos Trindade Filho, et al.
The Journal of Biological Chemistry|September 22, 2000
Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1)-MMP-dependent activation of pro-MMP-2M Toth, M M Bernardo, D C Gervasi, et al.
European Urology|July 28, 2023
Does Urologist-level Utilization of Active Surveillance for Low-risk Prostate Cancer Correspond with Utilization of Active Surveillance for Small Renal Masses?Michael Wang, Sophie Wittenberg, Michael L Cher, et al.
The Journal of Urology|July 17, 2016
Appropriateness Criteria for Active Surveillance of Prostate CancerMichael L Cher, Apoorv Dhir, Gregory B Auffenberg, et al.
Pageof 16